By Counterforce Health Team in Retevmo (selpercatinib) —

Do You Qualify for Retevmo (Selpercatinib) Coverage by UnitedHealthcare in Florida? Decision Tree & Next Steps

Quick Answer: Getting Retevmo (Selpercatinib) Covered by UnitedHealthcare in Florida

You likely qualify for Retevmo coverage if you have RET fusion-positive cancer confirmed by FDA-approved testing and haven't responded to or can't tolerate standard treatments. UnitedHealthcare requires prior authorization through OptumRx. Submit via the UnitedHealthcare provider portal or call 800-310-6826. Include RET testing results, treatment history, and a medical necessity letter. If denied, Florida allows internal appeals (180 days) followed by external review through the Department of Financial Services. Most oncology drug appeals succeed with proper documentation.

Table of Contents

  1. How to Use This Guide
  2. Eligibility Triage: Do You Qualify?
  3. If You're Likely Eligible: Document Checklist
  4. If You're Possibly Eligible: Tests to Request
  5. If You're Not Yet Eligible: Alternatives
  6. If Denied: Florida Appeals Process
  7. Common Denial Reasons & Solutions
  8. Costs & Patient Assistance
  9. FAQ: UnitedHealthcare & Retevmo in Florida

How to Use This Guide

This decision tree helps patients and clinicians navigate Retevmo (selpercatinib) coverage with UnitedHealthcare in Florida. Start with the eligibility triage below to determine your pathway. Each section includes specific documents, timelines, and contact information verified from official sources.

Note: This guide covers commercial UnitedHealthcare plans and Medicare Advantage. Medicaid coverage may differ—contact your plan directly.

Eligibility Triage: Do You Qualify?

Coverage Requirements at a Glance

Requirement What It Means Where to Find It Status
RET Testing FDA-approved companion diagnostic showing RET fusion/mutation Pathology report, NGS results Required
Cancer Type NSCLC, medullary thyroid, or other RET+ solid tumors Oncology notes, pathology Required
Prior Authorization OptumRx review before coverage Provider portal submission Required
Treatment History Documentation of failed/contraindicated alternatives Medical records Usually required

Answer these questions to determine your pathway:

1. Diagnosis Confirmed?

  • Yes, RET fusion-positive cancer confirmed by NGS testing → Continue to question 2
  • Yes, but only tissue available (no RET testing yet) → Go to Tests to Request
  • No confirmed cancer diagnosis → Work with oncologist for diagnosis first

2. Prior Treatment History?

3. Required Lab Work Current?

  • Recent liver function, ECG, and performance status documented → Proceed with application
  • Missing baseline labs → Request from oncologist before submission

If You're Likely Eligible: Document Checklist

Step-by-Step: Fastest Path to Approval

1. Gather RET Testing Documentation (Patient/Clinic)

  • NGS report from FDA-approved test (FoundationOne CDx, Tempus xR, Guardant360, or Oncomine Dx)
  • Laboratory name and test method clearly stated
  • Timeline: Should be available within 1-2 weeks of testing

2. Compile Treatment History (Clinic)

  • Complete chemotherapy records with dates, doses, and responses
  • Documentation of treatment failures or intolerances with specific reasons
  • Timeline: Medical records team can usually provide within 3-5 business days

3. Medical Necessity Letter (Oncologist)

  • Must include: RET testing details, cancer staging, prior treatments, clinical rationale
  • Reference FDA approval for your specific indication
  • Timeline: Allow 1-2 business days for physician completion

4. Submit Prior Authorization (Clinic Staff)

  • Via UnitedHealthcare Provider Portal or call 800-310-6826
  • Include all documentation from steps 1-3
  • Timeline: UnitedHealthcare has 72 hours for expedited, 14 days for standard review

Medical Necessity Letter Checklist

Your oncologist's letter should include these elements for the strongest case:

Patient Information

  • Full name, date of birth, UnitedHealthcare member ID
  • Cancer diagnosis with ICD-10 codes
  • Prescribing physician NPI and contact information

Clinical Justification

  • Confirmed RET fusion-positive cancer with testing laboratory and method
  • Complete prior treatment history with specific therapies, duration, and outcomes
  • Current disease status and symptoms
  • FDA approval rationale for Retevmo in this indication
  • Safety considerations addressed (cardiac monitoring, drug interactions)

Supporting Evidence

  • NCCN guideline references for your cancer type
  • FDA label information for Retevmo
  • Published studies if available
From Our Advocates: We've seen the strongest approvals when oncologists include a one-paragraph summary of why standard treatments won't work for this specific patient, citing both the patient's treatment history and the unique mechanism of RET inhibition that makes Retevmo the appropriate choice.

If You're Possibly Eligible: Tests to Request

Required RET Testing

If you have confirmed cancer but no RET testing yet, request these from your oncologist:

First Choice: Tissue-Based NGS

  • FoundationOne CDx (comprehensive genomic profiling)
  • Tempus xR IVD (RNA-based, high sensitivity for fusions)
  • Oncomine Dx Target Test
  • Advantage: Gold standard for detecting RET fusions

Alternative: Liquid Biopsy

  • FoundationOne Liquid CDx (blood-based)
  • Guardant360 CDx
  • Advantage: Non-invasive, faster results
  • Limitation: May miss up to 30% of RET alterations

What to Track While Waiting

  • Testing timeline: NGS results typically take 7-14 days
  • Insurance pre-authorization: Some plans require approval for testing
  • Backup samples: Ensure adequate tissue available for repeat testing if needed

Timeline to Re-apply: Once RET testing confirms fusion/mutation, you can immediately proceed with Retevmo prior authorization using the document checklist above.

If You're Not Yet Eligible: Alternatives

Standard Treatment Options to Discuss

Before Retevmo approval, UnitedHealthcare typically requires documentation that you've tried or can't tolerate:

For RET+ NSCLC:

  • Platinum-based chemotherapy (carboplatin/cisplatin + pemetrexed)
  • Immune checkpoint inhibitors (if no contraindications)

For RET+ Medullary Thyroid Cancer:

  • Cabozantinib or vandetanib (FDA-approved for progressive MTC)

For RET+ Thyroid Cancer:

  • Radioactive iodine therapy (if iodine-avid)
  • Lenvatinib or sorafenib

Preparing for Exception Requests

If standard treatments aren't appropriate for your situation, document:

Medical Contraindications

  • Specific reasons why standard treatments are contraindicated
  • Relevant comorbidities or prior adverse reactions
  • Performance status limitations

Urgent Clinical Need

  • Rapidly progressive disease
  • Symptomatic tumor burden
  • Limited treatment options due to prior therapies

Timeline: Exception requests typically take 7-14 days for review. Request expedited review if clinically urgent.

If Denied: Florida Appeals Process

UnitedHealthcare Appeals Levels

Level Type Filing Deadline Decision Timeline How to Submit
Level 1 Internal reconsideration 180 days from denial 30 days standard, 72 hours expedited UnitedHealthcare portal or 1-800-711-4555
Level 2 Independent review (IRE) 60 days from Level 1 denial 30 days standard, 72 hours expedited Automatically forwarded if eligible

Florida External Review Process

If internal appeals fail, Florida offers independent external review through the Department of Financial Services:

Filing Requirements

  • Must exhaust internal appeals first (unless expedited)
  • Submit within 4 months of final internal denial
  • No cost to consumer

Contact Information

  • Phone: 1-877-MY-FL-CFO (877-693-5236)
  • Online complaint system available
  • External review decisions are binding on the insurer

Appeals Documentation Checklist

For All Appeals Include:

  • Original denial letter
  • Complete medical records supporting medical necessity
  • Updated physician letter addressing specific denial reasons
  • Any new clinical information or test results

For Expedited Appeals (Life-Threatening Situations):

  • Physician attestation of urgent medical need
  • Documentation of disease progression or symptoms
  • Statement that delay could jeopardize health

Common Denial Reasons & Solutions

Denial Reason How to Overturn Required Documentation
"RET testing not documented" Submit NGS report from FDA-approved test Laboratory report with method and results
"Step therapy not met" Document failed prior treatments or contraindications Treatment records, adverse event notes
"Not medically necessary" Strengthen clinical justification Updated physician letter, NCCN guidelines
"Experimental/investigational" Cite FDA approval for indication FDA label, clinical trial data

Costs & Patient Assistance

Retevmo Pricing

  • Cash price: $23,000-$26,000 per 30-day supply
  • UnitedHealthcare copay: Varies by plan (typically $50-$500/month for specialty tier)

Financial Assistance Options

Lilly Cares Foundation

  • Income-based assistance for eligible patients
  • Apply at LillyCares.com
  • May cover full cost if uninsured or underinsured

Retevmo Copay Savings Card

  • Available for commercially insured patients
  • May reduce copay to as low as $10/month
  • Details at Retevmo.com

Florida-Specific Resources

Counterforce Health specializes in turning insurance denials into successful appeals for specialty medications like Retevmo. Their platform analyzes denial letters and creates evidence-backed appeals tailored to each payer's specific requirements, helping patients get life-saving treatments approved faster.

FAQ: UnitedHealthcare & Retevmo in Florida

How long does UnitedHealthcare prior authorization take in Florida? Standard prior authorization decisions take up to 14 days. Expedited reviews (for urgent cases) are completed within 72 hours. You can track status through the UnitedHealthcare provider portal.

What if Retevmo is non-formulary on my plan? Non-formulary drugs can still be covered through prior authorization with strong medical necessity documentation. Focus on demonstrating lack of effective formulary alternatives and FDA approval for your specific indication.

Can I request an expedited appeal if my cancer is progressing? Yes. Document rapid disease progression, symptomatic tumor burden, or urgent clinical need. Your oncologist must attest that delay could jeopardize your health or life.

Does step therapy apply if I failed treatments in another state? Treatment history from other states is valid. Ensure complete medical records are transferred and clearly document specific treatments tried, duration, and reasons for discontinuation.

What happens if my appeal is denied at all levels? After exhausting UnitedHealthcare's internal appeals and Florida's external review, you may have legal options. Consult with a healthcare attorney who specializes in insurance coverage disputes.

Can I get Retevmo while my appeal is pending? UnitedHealthcare may approve temporary coverage during appeals for life-threatening conditions. Request this specifically and provide documentation of urgent medical need.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance plan for specific coverage decisions. For assistance with insurance issues in Florida, contact the Department of Financial Services at 1-877-MY-FL-CFO.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.